Article Details
Retrieved on: 2021-05-25 19:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Apellis' C3 inhibitor Empaveli helped patients regardless of prior treatment with Alexion's Soliris in a phase 3 study. (Apellis Pharmaceuticals).
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here